About this event

  • Date and time Tue 1 Apr 2025 from 10:00am to 5:00pm
  • Location Royal Society of Medicine
  • Organised by Vascular, Lipid and Metabolic Medicine Section

Recent advancements have significantly improved the identification of individuals at high risk of cardiovascular events and the management of their modifiable risk factors. However, there is increasing recognition that certain patient groups remain under-assessed and under-treated for their cardiovascular risks.

Join this meeting to explore how standard cardiovascular risk assessments can be enhanced for specific groups. Gain practical strategies for incorporating additional risk factors and effectively managing these risks to improve outcomes.

By attending, participants will learn to assess and manage the cardiovascular risk in:

  • Patients with chronic conditions like rheumatological diseases, HIV, liver disease, chronic kidney disease, diabetes, or metabolic disorders
  • Patients with diabetes, metabolic syndrome and metabolic-associated steato-hepatitis
  • Females and individuals of South Asian and Afro-Caribbean heritage, and other ethnic groups

 

Follow us on: 

Facebook 
Instagram 
LinkedIn 
Twitter 
YouTube 

 

Tickets

Standard pricing available until 31 March 2025.

Member

RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£60.00 £46.00 £46.00 £35.00 £20.00

Non - Member

Consultant / GP / SAS Doctors AHP / Nurse / Midwife Trainee Student
£120.00 £84.00 £70.00 £30.00

Agenda

View the programme

Session 1

Welcome and introduction

Dr Paul Flynn, President-Elect, Vascular, Lipid and Metabolic Medicine Section, Royal Society of Medicine

Chronic rheumatological disease

Professor Dorian Haskard, Professor of Cardiovascular Medicine and Rheumatology, Imperial College, London

HIV

Dr Sonia Raffe, Consultant in Sexual Health and HIV, The Lawson Unit, University Hospitals Sussex NHS Foundation Trust, Brighton

Tea and coffee break

Session 2

Lipoprotein X in cholestatic liver disease

Speaker to be confirmed

Chronic kidney disease

Dr Janaka Karalliedde, Clinical Senior Lecturer, School of Cardiovascular Medicine and Sciences, King’s College, London

Lunch

Session 3

Type 1 diabetes

Dr Paul Flynn, Consultant in Metabolic Medicine, Addenbrooke’s Hospital, Cambridge

Type 2 diabetes, metabolic syndrome and MASLD

Professor Chris Byrne, Professor of Endocrinology and Metabolism, University of Southampton

Discussion
Tea and coffee break

Session 4

Women

Speaker to be confirmed

South Asians and other high risk ethnicities

Dr Tina Khan, Consultant Cardiologist and Honorary Clinical Senior Lecturer, Imperial College, London

Discussion
Closing remarks
Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Registrations for this event will close on 31 March 2025 at 10:00am (GMT).

The agenda is subject to change at any time.

If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenters and RSM's discretion. 

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations. 

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels. 

Domus - reception

While you’re attending this event

Why not stay in the comfort of our hotel, Domus Medica, book dinner in the restaurant, or even hire one of our private dining rooms to socialise with your peers?

RSM members enjoy access to our enviable club facilities. For more information, please contact our team at domus@rsm.ac.uk or restaurant@rsm.ac.uk.

Find out more
The Cornell Club - USA

Global reciprocal club network  

We have reciprocal club arrangements in place all over the globe for our members who regularly travel overseas, with clubs in Australia, India, the USA, Canada and Sri Lanka to name a few.